SecBot SecBot
8-K ·Filed Aug 13, 2026

BFRI

Biofrontera Inc.
BULLISH
Impact 7/10
Horizonweeks Processed2mo ago SEC0001493152-26-037610
8-K Item 2.02: Earnings release
Actionable Insight ▲ Bullish

The dramatic improvement in profitability and cash burn, combined with the upcoming PDUFA catalyst for sBCC (Sept 28), makes this a high-impact event for a $16M market cap stock. However, the ITC lamp exclusion order creates near-term uncertainty on Q3 revenue timing. Monitor the remediation plan progress and sBCC approval decision.

DirectionBullish
Confidencehigh
Horizonweeks
Latest settled — T+20d
BFRI ▲ +23.02% at T+20d
LONG call ✓ call won +23.02% · α vs SPY +24.76% · entry $1.26 → $1.55
Next anchor: T+60d in 11d
Latest observation: T+50 -53.32% FF3 residual α
Entry = T+0 close
Aug 13, 2026
via day close
T+1d
+3.17%
call +3.17% · α +3.37%
$1.30
settled 2mo ago
T+5d
+17.46%
call +17.46% · α +19.42%
$1.48
settled 2mo ago
T+20d
+23.02%
call +23.02% · α +24.76%
$1.55
settled 6w ago
T+60d
Pending
in 11d

Price Chart

Loading chart...

Executive Summary

Biofrontera reported Q2 2026 net product revenue of $12.0M (+32.9% YoY), a net loss of $0.6M ($-0.05/share) vs a $5.3M loss in Q2 2025, and Adjusted EBITDA of -$0.2M, nearing breakeven. The strong revenue growth and dramatic margin expansion (80% vs 71%) reflect the new earnout cost structure, though Q2 orders were partly pulled forward by an ITC exclusion order on the RhodoLED XL lamp. The company is approaching cash-flow breakeven with a PDUFA catalyst for sBCC in September 2026.

Key Financial Metrics

EPS
−$0.05
est −$0.17 · +70.6%
Revenue
$12.0M
est $9.5M · +26.4% · +32.9% YoY
Rating
strong beat
Gross Margin
80%

Key Facts

  • Net product revenue of $12.0M, +32.9% YoY from $9.0M
  • Gross margin of 80%, up ~920 bps from 71% in Q2 2025
  • Net loss narrowed to $0.6M ($-0.05/share) from $5.3M ($-0.57/share)
  • Adjusted EBITDA of -$0.2M, compared to -$5.1M in Q2 2025
  • Operating cash used in H1 2026 was $1.7M, down 76% from $7.2M
  • Cash and cash equivalents of $4.7M as of June 30, 2026
  • PDUFA target action date for sBCC (Ameluz) is September 28, 2026
  • ITC exclusion order on RhodoLED XL lamp took effect July 7, 2026; remediation plan underway

Financial Impact

Revenue grew $3.0M (+32.9%) YoY; net loss improved by $4.7M; Adjusted EBITDA improved by $4.9M

revenuegross marginnet lossadjusted EBITDAoperating cash flow

Risk Factors

  • ITC exclusion order on RhodoLED XL lamp may shift Q3 orders and impact near-term revenue
  • Cash balance of $4.7M provides limited runway if profitability is not sustained
  • Pending sBCC PDUFA decision (Sept 28) is binary and could significantly expand or contract the commercial opportunity

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
88% bullish (8 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 6 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001493152-26-037610
Document: form8-k.htm0001493152-26-037610
Document: 0001493152-26-037610-index-headers.html0001493152-26-037610
Document: 0001493152-26-037610-index.html0001493152-26-037610
Document: 0001493152-26-037610.txt0001493152-26-037610
8-K Data (Synthetic)0001493152-26-037610
6 reports for BFRI
Performance horizon
67% Hit rate @ T+60 2 of 3 directional calls Went positive at some point 2 of 4 best @ T+20▲ +28.50%Mar 19, 2026
Filters
Rows
Reports for BFRI — sortable, filterable
TypeNow
Sep 14, 2026
5w ago
8-K
BULLISH ★ 7/10
$1.36awaiting T+60—$0.7890 (−41.99%)
Aug 13, 2026
10w ago
8-K
BULLISH ★ 7/10
$1.26awaiting T+60—$0.7890 (−37.38%)
May 14, 2026
23w ago
Press Release
BULLISH ★ 7/10
$0.9890 $1.21▲ +22.35%▲ +18.76%$0.7890 (−20.22%)
May 8, 2026
24w ago
Press Release
NEUTRAL ★ 1/10
$1.11 $1.24▲ +11.71%▲ +7.32%$0.7890 (−28.92%)
Mar 19, 2026
31w ago
Press Release
BULLISH ★ 8/10
$0.8560 $1.00▲ +16.82%▲ +2.48%$0.7890 (−7.83%)
Feb 26, 2026
34w ago
8-K
BULLISH ★ 8/10
$0.9270 $0.7790▼ −15.97%▼ −23.72%$0.7890 (−14.89%)
Showing 6 of 6

US Market Status

Market Closed — Opens in 22m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Aug 13, 2026